• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两个不同欧洲队列中新生血管性年龄相关性黄斑变性发病时患者的知晓情况及症状表现

Patients' awareness and presenting symptoms at the onset of neovascular age-related macular degeneration in two distinct European cohorts.

作者信息

Limoli Celeste, O'Toole Louise, Piccoli Gabriele, Nucci Paolo, Vujosevic Stela

机构信息

Eye Clinic, IRCCS MultiMedica, Milan, Italy.

University of Milan, Milan, Italy.

出版信息

Int Ophthalmol. 2025 Jul 21;45(1):304. doi: 10.1007/s10792-025-03679-z.

DOI:10.1007/s10792-025-03679-z
PMID:40690044
Abstract

PURPOSE

Neovascular age-related macular degeneration (nAMD) is a common ocular condition in the elderly population. If left untreated, it can lead to significant visual impairment. Prompt detection of the disease achieves better therapeutic outcomes. The goal of this study is to ascertain the presenting symptoms of nAMD from two different population groups.

METHODS

A questionnaire was distributed to two groups of patients with nAMD who attended intravitreal injection services in Milan and Dublin. Four age-subgroups were considered: 60-69, 70-79, 80-89, > 90 years. Patients completed an interview questionnaire regarding their symptoms at the time of diagnosis with nAMD. The patients were divided into two groups; Group A consisted of Italian patients and group B comprised Irish patients. Symptom differences between the groups were compared using the Chi-square test.

RESULTS

A total of 237 patients with nAMD were included in the study, with 136 in group A and 101 in group B. The most common age-subgroup was 80-89 years (49.8%); the majority 129(54.4%) patients were females. The most frequently reported symptom at the time of nAMD onset was distortion (n = 105, 44.3%). Notably, 50 patients (21.1%) were asymptomatic. The Irish patients were less aware of the onset of the symptoms of nAMD compared with their Italian counterparts(p < 0.001).

CONCLUSION

This study shows that 21.1% of patients with nAMD were asymptomatic at the onset of their condition. Symptom awareness was higher among the Italian cohort compared to the Irish group. Patients at risk for conversion to nAMD should attend regular OCT monitoring rather than relying on subjective symptoms alone.

摘要

目的

新生血管性年龄相关性黄斑变性(nAMD)是老年人群中常见的眼部疾病。若不及时治疗,可导致严重视力损害。及时发现该疾病可取得更好的治疗效果。本研究的目的是确定来自两个不同人群组的nAMD的首发症状。

方法

向在米兰和都柏林接受玻璃体内注射治疗的两组nAMD患者发放问卷。考虑了四个年龄亚组:60 - 69岁、70 - 79岁、80 - 89岁、>90岁。患者完成了一份关于nAMD诊断时症状的访谈问卷。患者分为两组;A组由意大利患者组成,B组由爱尔兰患者组成。使用卡方检验比较两组之间的症状差异。

结果

本研究共纳入237例nAMD患者,其中A组136例,B组101例。最常见的年龄亚组是80 - 89岁(49.8%);大多数129例(54.4%)患者为女性。nAMD发病时最常报告的症状是视物变形(n = 105,44.3%)。值得注意的是,50例患者(21.1%)无症状。与意大利患者相比,爱尔兰患者对nAMD症状发作的知晓度较低(p < 0.001)。

结论

本研究表明,21.1%的nAMD患者在疾病发作时无症状。意大利队列中的症状知晓度高于爱尔兰组。有转化为nAMD风险的患者应定期进行光学相干断层扫描(OCT)监测,而不是仅依赖主观症状。

相似文献

1
Patients' awareness and presenting symptoms at the onset of neovascular age-related macular degeneration in two distinct European cohorts.两个不同欧洲队列中新生血管性年龄相关性黄斑变性发病时患者的知晓情况及症状表现
Int Ophthalmol. 2025 Jul 21;45(1):304. doi: 10.1007/s10792-025-03679-z.
2
Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular Degeneration.高剂量8毫克阿柏西普治疗渗出性年龄相关性黄斑变性的初始功能和解剖学结果
Ophthalmol Retina. 2025 Aug;9(8):756-766. doi: 10.1016/j.oret.2025.02.002. Epub 2025 Feb 7.
3
Neovascular age-related macular degeneration on three nationwide survey and register data in Finland during 2000-2017.
Acta Ophthalmol. 2025 Jun;103(4):449-460. doi: 10.1111/aos.17444. Epub 2025 Jan 20.
4
Real-world evidence of anti-VEGF therapies in patients with neovascular age-related macular degeneration in Italy: The RADIANCE study.意大利新生血管性年龄相关性黄斑变性患者抗VEGF治疗的真实世界证据:RADIANCE研究。
Eur J Ophthalmol. 2025 Jul;35(4):1366-1375. doi: 10.1177/11206721241310628. Epub 2025 Feb 3.
5
Comparable choroidal thickness between treated eyes and untreated fellow-eyes in patients with unilateral neovascular AMD: a paired-eyes comparative study.单侧新生血管性年龄相关性黄斑变性患者治疗眼与未治疗对侧眼脉络膜厚度的比较:配对眼比较研究。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar 8. doi: 10.1007/s00417-025-06751-7.
6
Real-world outcomes of a loading phase with intravitreal faricimab in refractory Neovascular Age-Related Macular Degeneration (nAMD) patients.玻璃体内注射法西单抗负荷期治疗难治性新生血管性年龄相关性黄斑变性(nAMD)患者的真实世界疗效
BMC Ophthalmol. 2025 Jul 1;25(1):347. doi: 10.1186/s12886-025-04212-7.
7
Association of plasma metabolites with treatment response after intravitreal anti-vascular endothelial growth factor injections in treatment-naïve neovascular age-related macular degeneration.初治新生血管性年龄相关性黄斑变性患者玻璃体内注射抗血管内皮生长因子后血浆代谢物与治疗反应的关联
BMJ Open Ophthalmol. 2025 Mar 15;10(1):e002149. doi: 10.1136/bmjophth-2025-002149.
8
Long-term observational data on neovascular age-related macular degeneration: a 10-year follow-up study.新生血管性年龄相关性黄斑变性的长期观察数据:一项10年随访研究。
Int Ophthalmol. 2025 Jul 1;45(1):273. doi: 10.1007/s10792-025-03644-w.
9
Impact of Duration of Exposure to Intraretinal Fluid on Visual Outcomes in Neovascular Age-Related Macular Degeneration.视网膜内液暴露时间对新生血管性年龄相关性黄斑变性视觉预后的影响
Ophthalmol Retina. 2025 Jul;9(7):618-624. doi: 10.1016/j.oret.2024.12.018. Epub 2024 Dec 16.
10
Persistence of Retinal Fluid after Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性后视网膜下液的持续存在:一项系统评价和荟萃分析
Ophthalmol Retina. 2025 Jan 20. doi: 10.1016/j.oret.2025.01.010.

本文引用的文献

1
Evaluation of a self-imaging SD-OCT system designed for remote home monitoring.用于远程家庭监测的自成像 SD-OCT 系统的评估。
BMC Ophthalmol. 2022 Jun 10;22(1):261. doi: 10.1186/s12886-022-02458-z.
2
Real-life patient journey in neovascular age-related macular degeneration: a narrative medicine analysis in the Italian setting.新生血管性年龄相关性黄斑变性患者的真实就医历程:意大利背景下的叙事医学分析
Eye (Lond). 2022 Jan;36(1):182-192. doi: 10.1038/s41433-021-01470-9. Epub 2021 Mar 5.
3
Digital Technology for AMD Management in the Post-COVID-19 New Normal.
用于后 COVID-19 新常态下 AMD 管理的数字技术。
Asia Pac J Ophthalmol (Phila). 2021;10(1):39-48. doi: 10.1097/APO.0000000000000363.
4
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group.《关于新生血管性年龄相关性黄斑变性数据报告的共识命名法:新生血管性年龄相关性黄斑变性命名法研究组的共识》。
Ophthalmology. 2020 May;127(5):616-636. doi: 10.1016/j.ophtha.2019.11.004. Epub 2019 Nov 14.
5
Age-Related Macular Degeneration Preferred Practice Pattern®.年龄相关性黄斑变性首选实践模式®
Ophthalmology. 2020 Jan;127(1):P1-P65. doi: 10.1016/j.ophtha.2019.09.024. Epub 2019 Sep 25.
6
Investigation of time to first presentation and extrahospital factors in the treatment of neovascular age-related macular degeneration: a retrospective cross-sectional study.新生血管性年龄相关性黄斑变性治疗中首次就诊时间及院外因素的调查:一项回顾性横断面研究
BMJ Open. 2017 Dec 10;7(12):e017771. doi: 10.1136/bmjopen-2017-017771.
7
Updates on the Epidemiology of Age-Related Macular Degeneration.年龄相关性黄斑变性的流行病学最新进展。
Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):493-497. doi: 10.22608/APO.2017251. Epub 2017 Sep 14.
8
Awareness of Age-related Macular Degeneration and Its Risk Factors among Beijing Residents in China.中国北京居民对年龄相关性黄斑变性及其危险因素的认知
Chin Med J (Engl). 2017 Jan 20;130(2):155-159. doi: 10.4103/0366-6999.197994.
9
Public Attitudes About Eye and Vision Health.公众对眼睛和视力健康的态度。
JAMA Ophthalmol. 2016 Oct 1;134(10):1111-1118. doi: 10.1001/jamaophthalmol.2016.2627.
10
Visual acuity at presentation in the second eye versus first eye in patients with exudative age-related macular degeneration.
Eur J Ophthalmol. 2016 Jan-Feb;26(1):44-7. doi: 10.5301/ejo.5000649. Epub 2015 Jul 8.